Home » Stocks » TEVA

Teva Pharmaceutical Industries Ltd. (TEVA)

Stock Price: $11.97 USD -0.21 (-1.72%)
Updated Jan 21, 2021 4:00 PM EST - Market closed
Pre-market: $11.79 -0.18 (-1.50%) Jan 22, 7:41 AM
Market Cap 13.59B
Revenue (ttm) 16.20B
Net Income (ttm) -4.03B
Shares Out 1.10B
EPS (ttm) -3.69
PE Ratio n/a
Forward PE 4.54
Dividend n/a
Dividend Yield n/a
Trading Day January 21
Last Price $11.97
Previous Close $12.18
Change ($) -0.21
Change (%) -1.72%
Day's Open 12.22
Day's Range 11.82 - 12.28
Day's Volume 5,562,453
52-Week Range 6.69 - 13.45

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
The Motley Fool - 5 days ago

Things are looking up for these beaten-down value plays in the new year.

Other stocks mentioned: KL, WBA
Schaeffers Research - 6 days ago

The shares of Teva Pharmaceutical Industries Ltd (NYSE:TEVA) are up 0.4% at $11.54 this morning, after the company announced plans to launch a generic version of Merck's (MRK) birth control de...

Business Wire - 1 week ago

TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd.(NYSE and TASE: TEVA), today announced the availabi...

Seeking Alpha - 1 week ago

Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on 39th Annual JP Morgan Healthcare Conference Transcript

Other stocks mentioned: JPM
InvestorPlace - 1 week ago

With proper research and long-term investing, $1 million can easily be in reach. Check out these stocks that could make you a millionaire.

Other stocks mentioned: AAXN, BAND, CLDR, LOVE, LOW, SYNA
The Motley Fool - 1 week ago

Bargains are plentiful for value investors in the new year.

Other stocks mentioned: AUY, EXEL, WBA, WFC
Business Wire - 1 week ago

TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its fourth quarter and full year 2020 financi...

Business Wire - 2 weeks ago

TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that President & CEO Kåre Schultz will present at the 39th Annual J.P. Morgan Healt...

Business Wire - 2 weeks ago

TEL AVIV, Israel & PARIS--(BUSINESS WIRE)--Teva Pharmaceuticals Industries Ltd. (NYSE and TASE: TEVA) and MedinCell (Euronext: MEDCL) today announced positive results for study TV46000-CNS-300...

The Motley Fool - 2 weeks ago

These time-tested Buffett holdings can pump up your portfolio.

Other stocks mentioned: AMZN, BRK.A, BRK.B, GOLD, WFC
InvestorPlace - 2 weeks ago

Warren Buffett stocks have been a mixed bag during this bull market. These four names are the weakest in Berkshire's portfolio.

Other stocks mentioned: KO, WFC, AXP
The Motley Fool - 2 weeks ago

Triple-digit returns could be just a click of the buy button away.

Other stocks mentioned: CLDR, CRLBF, EVER, JUSHF, LOVE, OGI, SSRM
The Motley Fool - 3 weeks ago

This Fool is counting on five growth and value stocks to power his portfolio higher in the new year.

Other stocks mentioned: AG, PINS, SSRM, TDOC
The Motley Fool - 1 month ago

There's something for every type of value investor.

Other stocks mentioned: AMZN, WFC
Zacks Investment Research - 1 month ago

3 Generic Drug Stocks to Watch Amid COVID-Induced Uncertainty

Other stocks mentioned: BHC, RDY
Zacks Investment Research - 1 month ago

Is Teva Pharmaceutical (TEVA) a great pick from the value investor's perspective right now? Read on to know more.

Business Wire - 1 month ago

LOS ANGELES--(BUSINESS WIRE)---- $TEVA #TEVA--DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Teva Pharmaceuticals Industries Limited

Benzinga - 2 months ago

Berkshire Hathaway Inc. (NYSE: BRK-A) (NYSE: BRK-B) CEO Warren Buffett is one of the world's richest people, with a net worth of around $86 billion. Unfortunately for small retail investors wh...

Other stocks mentioned: GOLD, LILA, LILAK, SIRI, SU
Newsfile Corp - 2 months ago

Los Angeles, California--(Newsfile Corp. - November 20, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Teva ...

Newsfile Corp - 2 months ago

Los Angeles, California--(Newsfile Corp. - November 19, 2020) -  The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Teva...

Newsfile Corp - 2 months ago

Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp...

Newsfile Corp - 2 months ago

Los Angeles, California--(Newsfile Corp. - November 18, 2020) -  The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Teva...

Newsfile Corp - 2 months ago

Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp...

Newsfile Corp - 2 months ago

Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp...

PRNewsWire - 2 months ago

NEW YORK, Nov. 14, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds the purchasers of the securities of Teva Pharmaceuticals Industries Limited (NYSE: TEVA) betw...

Newsfile Corp - 2 months ago

Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp...

Seeking Alpha - 2 months ago

Teva's revenues disappointed, but this was likely due to COVID-dependent market volatility. In contrast, margins were up significantly, which should benefit long-term shareholders over time.

The Motley Fool - 2 months ago

Bargains abound for patient value investors.

Other stocks mentioned: FLR, NLY, WFC
Newsfile Corp - 2 months ago

Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp...

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - November 11, 2020) - Rosen Law Firm, a global investor rights law firm, reminds the purchasers of the securities of Teva Pharmaceuticals Industries Limite...

Zacks Investment Research - 2 months ago

When it comes to valuation metrics, though P/E and P/S are the first choices, the P/B ratio is also emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.

Other stocks mentioned: ATCO, BCC, CSIQ, LH, PAM
Newsfile Corp - 2 months ago

Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp...

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - November 7, 2020) -  Rosen Law Firm, a global investor rights law firm, reminds the purchasers of the securities of Teva Pharmaceuticals Industries Limite...

Zacks Investment Research - 2 months ago

TEVA's earnings match estimates while sales miss the same for third-quarter 2020. It lowers its previously issued sales guidance for 2020.

Seeking Alpha - 2 months ago

Teva Pharmaceutical Industries Ltd (TEVA) CEO Kare Schultz on Q3 2020 Results - Earnings Call Transcript

Investors Business Daily - 2 months ago

Early Thursday, Teva Pharmaceutical reported adjusted earnings of 58 cents per share on $3.98 billion in sales for its third quarter ended Sept. 30. In response, Teva stock slipped.

Zacks Investment Research - 2 months ago

TEVA's earnings match estimates while sales miss the same in third-quarter 2020. It maintains its previously issued guidance for 2020.

Market Watch - 2 months ago

Shares of Teva Pharmaceutical Industries Ltd. gained 0.4% in premarket trading on Thursday after it beat revenue expectations for the third quarter.

Business Wire - 2 months ago

TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) today reported results for the quarter ended September 30, 2020. Mr. Kåre Schultz, Teva's Presid...

Insider Monkey - 2 months ago

Miller Value Partners recently released its Q3 2020 Investor Letter, a copy of which you can download here. The Opportunity Equity Fund posted a return of 13.01% for the quarter (net of fees),...

Zacks Investment Research - 2 months ago

On Teva's (TEVA) third-quarter conference call, investors will look for updates on the extent to which the coronavirus pandemic may have impacted sales of its products.

PRNewsWire - 2 months ago

NEW YORK, Oct. 31, 2020 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Teva Pharmaceuticals Industries Limited ("Teva" or the "Company") (NYSE: TEVA...

The Motley Fool - 2 months ago

You probably shouldn't invest in these healthcare stocks unless you're betting on a turnaround, and soon.

Other stocks mentioned: RAD
PRNewsWire - 2 months ago

NEW YORK, Oct. 30, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds the purchasers of the securities of Teva Pharmaceuticals Industries Limited (NYSE: TEVA) betw...

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - October 28, 2020) -  Rosen Law Firm, a global investor rights law firm, reminds the purchasers of the securities of Teva Pharmaceuticals Industries Limite...

The Motley Fool - 2 months ago

Bargains abound for long-term investors.

Other stocks mentioned: CVS, MO, T
Zacks Investment Research - 3 months ago

When it comes to valuation metrics, though P/E and P/S are the first choices, the P/B ratio is also emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.

Other stocks mentioned: ATCO, BEN, CNC, SPB, VIAC
Newsfile Corp - 3 months ago

New York, New York--(Newsfile Corp. - October 17, 2020) -  Rosen Law Firm, a global investor rights law firm, reminds the purchasers of the securities of Teva Pharmaceuticals Industries Limite...

Newsfile Corp - 3 months ago

New York, New York--(Newsfile Corp. - October 15, 2020) -   Faruqi & Faruqi, LLP, a leading minority and certified woman-owned national securities law firm, is investigating claims against Tev...

PRNewsWire - 3 months ago

NEW YORK, Oct. 15, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds the purchasers of the securities of Teva Pharmaceuticals Industries Limited (NYSE: TEVA) betw...

About TEVA

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, the company provides spec... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
Founded
1901
CEO
Kaare Schultz
Employees
40,039
Stock Exchange
NYSE
Ticker Symbol
TEVA
Full Company Profile

Financial Performance

In 2019, TEVA's revenue was $16.89 billion, a decrease of -7.57% compared to the previous year's $18.27 billion. Losses were -$999.00 million, -53.53% less than in 2018.

Financial Statements

Analyst Forecasts

According to 25 analysts, the average rating for TEVA stock is "Hold." The 12-month stock price forecast is 11.82, which is a decrease of -1.25% from the latest price.

Price Target
$11.82
(-1.25% downside)
Analyst Consensus: Hold